Figure 3.
Effects of MyD88 inhibition on p-TAK1, IκBα, and p65 expression 24 h post SAH. Western blots show TAK1, p-TAK1 (a), IκBα (b) and p65 (c) levels following SAH. The upper panel shows representative protein levels of TAK1, p-TAK1, IκBα, and p65. The bottom panels are quantitative data of p-TAK1, IκBα, and p65. Tubulin and histone-3 were used as loading controls. Data are expressed as mean ± SD (n = 6 in each group). p-TAK1, phosphorylated transforming growth factor-β-activated kinase 1, IκBα, inhibitor of NF-κB, Definition of SAH is the same as in Fig. 2. *p < 0.05 compared with the sham group, ***p < 0.001 compared with the sham group, #p < 0.05 compared with the SAH group, ##p < 0.01 compared with the SAH group, ###p < 0.001 compared with the SAH group, NS, no statistic difference compared with the SAH group.